Connection

Adviye Ergul to Humans

Back to Details
This is a "connection" page, showing publications Adviye Ergul has written about Humans.
Adviye Ergul
Connection Strength
0.792
Humans
  1. Endothelin A receptors contribute to senescence of brain microvascular endothelial cells. Can J Physiol Pharmacol. 2022 Dec 01; 100(12):1087-1096.
    View in: PubMed
    Score: 0.032
  2. Impact of diabetes and ischemic stroke on the cerebrovasculature: A female perspective. Neurobiol Dis. 2022 06 01; 167:105667.
    View in: PubMed
    Score: 0.030
  3. Deferoxamine Treatment Prevents Post-Stroke Vasoregression and Neurovascular Unit Remodeling Leading to Improved Functional Outcomes in Type 2 Male Diabetic Rats: Role of Endothelial Ferroptosis. Transl Stroke Res. 2021 08; 12(4):615-630.
    View in: PubMed
    Score: 0.027
  4. Diabetes-related sex differences in the brain endothelin system following ischemia in vivo and in human brain endothelial cells in vitro. Can J Physiol Pharmacol. 2020 Sep; 98(9):587-595.
    View in: PubMed
    Score: 0.027
  5. Endothelin-1 (ET-1) promotes a proinflammatory microglia phenotype in diabetic conditions. Can J Physiol Pharmacol. 2020 Sep; 98(9):596-603.
    View in: PubMed
    Score: 0.026
  6. Inflammation within the neurovascular unit: Focus on microglia for stroke injury and recovery. Pharmacol Res. 2019 09; 147:104349.
    View in: PubMed
    Score: 0.025
  7. Brain Vasculature and Cognition. Arterioscler Thromb Vasc Biol. 2019 04; 39(4):593-602.
    View in: PubMed
    Score: 0.025
  8. Endothelin and diabetic complications: a brain-centric view. Physiol Res. 2018 06 27; 67(Suppl 1):S83-S94.
    View in: PubMed
    Score: 0.024
  9. Lipopolysaccharide-induced necroptosis of brain microvascular endothelial cells can be prevented by inhibition of endothelin receptors. Physiol Res. 2018 06 27; 67(Suppl 1):S227-S236.
    View in: PubMed
    Score: 0.024
  10. Impact of Metabolic Diseases on Cerebral Circulation: Structural and Functional Consequences. Compr Physiol. 2018 03 25; 8(2):773-799.
    View in: PubMed
    Score: 0.023
  11. Within the Brain: The Renin Angiotensin System. Int J Mol Sci. 2018 Mar 15; 19(3).
    View in: PubMed
    Score: 0.023
  12. Cerebrovascular complications of diabetes: focus on cognitive dysfunction. Clin Sci (Lond). 2016 10 01; 130(20):1807-22.
    View in: PubMed
    Score: 0.021
  13. Nox4 contributes to the hypoxia-mediated regulation of actin cytoskeleton in cerebrovascular smooth muscle. Life Sci. 2016 Oct 15; 163:46-54.
    View in: PubMed
    Score: 0.021
  14. The Fourteenth International Conference on Endothelin (ET-14), Savannah, U.S.A. Life Sci. 2016 Aug 15; 159:2-9.
    View in: PubMed
    Score: 0.020
  15. Variations on a theme: ET-14 notes from mentor and trainees. Life Sci. 2016 Aug 15; 159:12-14.
    View in: PubMed
    Score: 0.020
  16. Response to Letter Regarding Article, "Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke". Stroke. 2016 06; 47(6):e173.
    View in: PubMed
    Score: 0.020
  17. Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes. Transl Stroke Res. 2016 08; 7(4):248-60.
    View in: PubMed
    Score: 0.020
  18. Diabetes-mediated middle cerebral artery remodeling is restored by linagliptin: Interaction with the vascular smooth muscle cell endothelin system. Life Sci. 2016 Aug 15; 159:76-82.
    View in: PubMed
    Score: 0.020
  19. Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period. Brain Res. 2015 Oct 14; 1623:81-96.
    View in: PubMed
    Score: 0.019
  20. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Transl Stroke Res. 2014 Aug; 5(4):442-453.
    View in: PubMed
    Score: 0.017
  21. Cerebral neovascularization in diabetes: implications for stroke recovery and beyond. J Cereb Blood Flow Metab. 2014 Apr; 34(4):553-63.
    View in: PubMed
    Score: 0.017
  22. Cerebrovascular complications of diabetes: focus on stroke. Endocr Metab Immune Disord Drug Targets. 2012 Jun; 12(2):148-58.
    View in: PubMed
    Score: 0.015
  23. Angiogenesis: a harmonized target for recovery after stroke. Stroke. 2012 Aug; 43(8):2270-4.
    View in: PubMed
    Score: 0.015
  24. Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res. 2011 Jun; 63(6):477-82.
    View in: PubMed
    Score: 0.014
  25. Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J Cereb Blood Flow Metab. 2010 Dec; 30(12):1928-38.
    View in: PubMed
    Score: 0.014
  26. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vascul Pharmacol. 2009 Jul; 51(1):44-9.
    View in: PubMed
    Score: 0.012
  27. Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes. J Pharmacol Exp Ther. 2009 Jan; 328(1):123-30.
    View in: PubMed
    Score: 0.012
  28. Elevated endothelin-1 levels are associated with decreased arterial elasticity in hypertensive patients. J Clin Hypertens (Greenwich). 2006 Aug; 8(8):549-54.
    View in: PubMed
    Score: 0.010
  29. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005 Apr 29; 4:5.
    View in: PubMed
    Score: 0.009
  30. Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy. 2005 Mar; 25(3):387-95.
    View in: PubMed
    Score: 0.009
  31. Oxidative stress and cardiovascular disease: antioxidants and unresolved issues. Cardiovasc Drug Rev. 2005; 23(2):115-32.
    View in: PubMed
    Score: 0.009
  32. Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1. J Pharmacol Exp Ther. 2005 Apr; 313(1):70-7.
    View in: PubMed
    Score: 0.009
  33. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients. Am J Hypertens. 2004 Sep; 17(9):775-82.
    View in: PubMed
    Score: 0.009
  34. Targets for vascular protection after acute ischemic stroke. Stroke. 2004 Sep; 35(9):2220-5.
    View in: PubMed
    Score: 0.009
  35. Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. Am J Hematol. 2004 Jul; 76(3):245-51.
    View in: PubMed
    Score: 0.009
  36. Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits. Chest. 2004 May; 125(5):1853-8.
    View in: PubMed
    Score: 0.009
  37. Nuclear localization of endothelin-converting enzyme-1: subisoform specificity. Arterioscler Thromb Vasc Biol. 2003 Dec; 23(12):2192-6.
    View in: PubMed
    Score: 0.008
  38. Saphenous vein endothelin system expression and activity in African American patients. Arterioscler Thromb Vasc Biol. 2002 Jul 01; 22(7):1122-7.
    View in: PubMed
    Score: 0.008
  39. p38 MAPK Is a Major Regulator of Amyloid Beta-Induced IL-6 Expression in Human Microglia. Mol Neurobiol. 2022 Sep; 59(9):5284-5298.
    View in: PubMed
    Score: 0.008
  40. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy. 2002 Jan; 22(1):54-65.
    View in: PubMed
    Score: 0.008
  41. Selective downregulation of endothelin-B receptors in diabetic African-American patients. Ethn Dis. 2002; 12(1):S1-46-50.
    View in: PubMed
    Score: 0.008
  42. Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes. Ethn Dis. 2002; 12(4):S3-5-9.
    View in: PubMed
    Score: 0.008
  43. Decreased vascular matrix metalloproteinase abundance in diabetic patients with symptomatic macroangiopathy. Ethn Dis. 2002; 12(4):S3-18-22.
    View in: PubMed
    Score: 0.008
  44. Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance. Heart Fail Rev. 2001 Dec; 6(4):287-94.
    View in: PubMed
    Score: 0.007
  45. A review of endothelin and hypertension in African-American individuals. Ethn Dis. 2001; 11(4):741-8.
    View in: PubMed
    Score: 0.007
  46. Selective upregulation of endothelin converting enzyme-1a in the human failing heart. J Card Fail. 2000 Dec; 6(4):314-20.
    View in: PubMed
    Score: 0.007
  47. Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension. Hypertension. 2000 Jul; 36(1):62-7.
    View in: PubMed
    Score: 0.007
  48. Endothelial stromelysin1 regulation by the forkhead box-O transcription factors is crucial in the exudative phase of acute lung injury. Pharmacol Res. 2019 03; 141:249-263.
    View in: PubMed
    Score: 0.006
  49. RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial. J Neuroinflammation. 2018 Aug 13; 15(1):229.
    View in: PubMed
    Score: 0.006
  50. Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial. Stroke. 2017 10; 48(10):2885-2887.
    View in: PubMed
    Score: 0.006
  51. The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGF?-induced pulmonary fibrosis. Br J Pharmacol. 2015 Aug; 172(16):4173-88.
    View in: PubMed
    Score: 0.005
  52. Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy. PLoS One. 2014; 9(10):e110388.
    View in: PubMed
    Score: 0.005
  53. 25 years of endothelin research: the next generation. Life Sci. 2014 Nov 24; 118(2):77-86.
    View in: PubMed
    Score: 0.005
  54. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition. Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15; 307(6):R693-703.
    View in: PubMed
    Score: 0.004
  55. Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol. 2015 Apr; 51(2):766-78.
    View in: PubMed
    Score: 0.004
  56. Oxidative stress and cardiovascular risk in overweight children in an exercise intervention program. Child Obes. 2013 Feb; 9(1):15-21.
    View in: PubMed
    Score: 0.004
  57. AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. J Pharmacol Exp Ther. 2013 Feb; 344(2):348-59.
    View in: PubMed
    Score: 0.004
  58. Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke. 2011 Sep; 42(9):2633-5.
    View in: PubMed
    Score: 0.004
  59. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke. 2010 Oct; 41(10):2283-7.
    View in: PubMed
    Score: 0.003
  60. Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. Am J Physiol Heart Circ Physiol. 2009 Feb; 296(2):H489-96.
    View in: PubMed
    Score: 0.003
  61. beta-Adrenergic and endothelin receptor interaction in dilated human cardiomyopathic myocardium. J Card Fail. 2001 Jun; 7(2):129-37.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.